Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ZNF460 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ZNF330 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RSF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC7A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
PEA15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HMGXB4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MSR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MFN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GYPA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
MEX3C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZBTB8A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SCEL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MOS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TCONS_00029157 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SAFB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NCL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C2CD5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on